Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127558681 | 12755868 | 1 | I | 20160905 | 20160916 | 20160916 | EXP | PL-TEVA-691699ISR | TEVA | FLIS P,MEHRHOLZ D,BARANSKA-RYBAK W,NOWICKI R. DERMATOLOGICAL ADVERSE EFFECTS OF CARDIOLOGICAL DRUGS. A RETROSPECTIVE STUDY OF PATIENTS HOSPITALISED IN A DERMATOLOGICAL WARD IN GDANSK IN THE YEARS 2004-2013 AND A REVIEW OF THE LITERATURE. FOLIA CARDIOLOGICA. VOL 11 NO:186-193. | 0.00 | Y | 0.00000 | 20160916 | MD | PL | PL |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127558681 | 12755868 | 1 | SS | PERINDOPRIL | PERINDOPRIL | 1 | Y | 0 | |||||||||||
127558681 | 12755868 | 2 | PS | INDAPAMIDE. | INDAPAMIDE | 1 | Y | 74722 | |||||||||||
127558681 | 12755868 | 3 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Y | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127558681 | 12755868 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127558681 | 12755868 | Angioedema | |
127558681 | 12755868 | C-reactive protein increased | |
127558681 | 12755868 | Leukocytosis | |
127558681 | 12755868 | Lymphopenia | |
127558681 | 12755868 | Neutrophilia | |
127558681 | 12755868 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |